Adjunctive Use of Calcipotriene/Betamethasone Dipropionate Foam in a Real-World Setting Curtails the Cost of Biologics Without Reducing Efficacy in Psoriasis
Abstract Introduction Although the efficacy of monotherapy with biologics for psoriasis is well established, many patients fail to achieve complete plaque clearance from their initial biologic treatment alone. Adjunctive treatment with topical calcipotriene plus betamethasone dipropionate (Cal/BD) f...
Main Authors: | Jerry Bagel, Elise Nelson, James Zapata, Alexa Hetzel |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2020-10-01
|
Series: | Dermatology and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s13555-020-00454-z |
Similar Items
-
COMPARISON OF EFFICACY OF TOPICAL CALCIPOTRIENE PLUS BETAMETHASONE WITH CALCIPOTRIENE ALONE IN LOCALIZED VITILIGO
by: Usman Riaz, et al.
Published: (2019-04-01) -
Real-world experience of calcipotriene and betamethasone dipropionate foam 0.005%/0.064% in the treatment of adults with psoriasis in the United States
by: Jashin J. Wu, et al.
Published: (2019-07-01) -
Calcipotriene and Betamethasone Dipropionate PAD-Cream Demonstrates Greater Treatment Efficacy in Patients with Moderate-to-Severe Psoriasis Compared to Topical Suspension/Gel: A Subgroup Analysis of Two Phase 3 Studies
by: Linda Stein Gold, et al.
Published: (2023-07-01) -
Calcipotriene/betamethasone dipropionate for the treatment of psoriasis vulgaris: an evidence-based review
by: Patel NU, et al.
Published: (2017-09-01) -
Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: case series and review of the literature
by: Pinter A, et al.
Published: (2018-10-01)